yingweiwo

EBV

EBV

A member of the herpes virus family is the Epstein-Barr virus (EBV), also referred to as human herpesvirus 4. It is one of the most prevalent viruses in people. The EBV virus can be found everywhere. The majority of people contract EBV at some point in their lives. EBV is most frequently transmitted through bodily fluids, particularly saliva.In children, primary EBV infection is frequently asymptomatic; however, in adolescents and adults, 30%–50% of cases clinically manifest as infectious mononucleosis (IM). Nasopharyngeal carcinoma (NPC), infectious mononucleosis (IM), Burkitt lymphoma (BL), Hodgkin's disease, and other illnesses are also brought on by EBV. EBV infection frequently occurs in children. In most cases, EBV infections in children do not result in symptoms, or if they do, they are similar to those of other mild, transient childhood illnesses.

EBV related products

Structure Cat No. Product Name CAS No. Product Description
11-Oxomogroside II A1 V54163 11-Oxomogroside II A1 942612-74-0 11-Oxomogroside II A1 (compound 7) is an oxidized cucurbitacin.
20-Hydroxylucidenic acid E2 V105951 20-Hydroxylucidenic acid E2 852567-75-0 20-Hydroxyleucine E2 is a triterpene compound found in Ganoderma lucidum. 20-Hydroxyleucine E2 has a significant inhibitory effect on TPA-induced inflammation. At the same time, 20-Hydroxyleucine E2 can also inhibit TPA-induced EBV early antigen expression, with an IC50 of 290 molar ratio/32 pmol TPA (equivalent to a molar concentration of the compound that is 290 times that of TPA (32 pmol) and can inhibit 50% of EBV early antigen expression).
Cabenoside D V52306 Cabenoside D 88901-40-0 Cabenoside D (compound 8) is a triterpene glycoside that was extracted from the methanol extract of moss roots.
Cimigenol-3-one V54164 Cimigenol-3-one 31222-32-9 Cimigenol-3-one inhibits activation of Epstein-Barr virus early antigen (EBV-EA).
EBV EBNA3A (379-387) V98090 EBV EBNA3A (379-387) 160790-25-0 EBV EBNA3A (379-387) is an epitope that may elicit latency-specific CD8+ T-cell responses in HLA-B*07:02+ individuals.
EBV lytic cycle inducer-1 V52163 EBV lytic cycle inducer-1 394668-43-0 Epstein-Barr virus (EBV) lytic cycle inducer-1 Dp44mT (Compound C7) is an iron chelate-like compound.
Ganolactone V105908 Ganolactone 173268-82-1 Janolide is a triterpenoid compound that has a weak inhibitory effect on EBV early antigens.
IALYLQQNW V99707 IALYLQQNW 610268-80-9 IALYLQQNW is a specific nonapeptide sequence derived from the tumor-associated antigen latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus (EBV).
Methyl lucidenate L V106090 Methyl lucidenate L 110267-46-4 Methylleucine L is a natural triterpene acid methyl ester that inhibits the activation of EBV (Epstein-Barr virus).
VK-1727 V76356 VK-1727 VK-1727 is a selective small molecule inhibitor of EBNA1 that reduces the DNA binding activity of EBNA1.
VK-1850 V50960 VK-1850 EBNA1 (Epstein-Barr nuclear antigen1) inhibitor
α-Cembrenediol (α-CBD) V76300 α-Cembrenediol (α-CBD) 57605-80-8 α-Cembrenediol is a potent inhibitor of EBV.
α-Toxicarol V76301 α-Toxicarol 82-09-7 α-Toxicarol is a potent inhibitor of EBV.
Contact Us